HRMY logo

HRMY Selling, General & Administrative Expenses

Annual SG&A:

$221.27M+$28.57M(+14.83%)
December 31, 2024

Summary

  • As of today, HRMY annual SG&A is $221.27 million, with the most recent change of +$28.57 million (+14.83%) on December 31, 2024.
  • During the last 3 years, HRMY annual SG&A has risen by +$89.24 million (+67.59%).
  • HRMY annual SG&A is now at all-time high.

Performance

HRMY SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYincome statement metrics

Quarterly SG&A:

$59.36M-$4.64M(-7.25%)
September 30, 2025

Summary

  • As of today, HRMY quarterly SG&A is $59.36 million, with the most recent change of -$4.64 million (-7.25%) on September 30, 2025.
  • Over the past year, HRMY quarterly SG&A has increased by +$3.19 million (+5.69%).
  • HRMY quarterly SG&A is now -7.25% below its all-time high of $64.00 million, reached on June 30, 2025.

Performance

HRMY Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYincome statement metrics

TTM SG&A:

$275.96M+$185.68M(+205.66%)
September 30, 2025

Summary

  • As of today, HRMY TTM SG&A is $275.96 million, with the most recent change of +$185.68 million (+205.66%) on September 30, 2025.
  • Over the past year, HRMY TTM SG&A has increased by +$56.40 million (+25.69%).
  • HRMY TTM SG&A is now at all-time high.

Performance

HRMY TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

HRMY Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+14.8%+5.7%+25.7%
3Y3 Years+67.6%+42.0%+75.9%
5Y5 Years+174.1%+156.8%+327.3%

HRMY Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+67.6%-7.3%+42.0%at high+117.1%
5Y5-Yearat high+174.1%-7.3%+156.8%at high+114.2%
All-TimeAll-Timeat high+661.2%-7.3%+484.6%at high+114.2%

HRMY Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$59.36M(-7.3%)
$241.77M(+1.3%)
Jun 2025
-
$64.00M(+3.3%)
$238.58M(+3.6%)
Mar 2025
-
$61.95M(+9.7%)
$230.31M(+4.1%)
Dec 2024
$221.27M(+14.8%)
$56.47M(+0.5%)
$221.27M(+0.8%)
Sep 2024
-
$56.16M(+0.8%)
$219.56M(+4.9%)
Jun 2024
-
$55.73M(+5.3%)
$209.36M(+4.2%)
Mar 2024
-
$52.91M(-3.4%)
$200.97M(+4.3%)
Dec 2023
$192.69M(+18.0%)
$54.76M(+19.1%)
$192.69M(+6.1%)
Sep 2023
-
$45.96M(-2.9%)
$181.65M(+2.3%)
Jun 2023
-
$47.34M(+6.1%)
$177.49M(+2.9%)
Mar 2023
-
$44.63M(+2.1%)
$172.47M(+5.6%)
Dec 2022
$163.30M
$43.72M(+4.6%)
$163.30M(+4.1%)
Sep 2022
-
$41.80M(-1.2%)
$156.90M(+5.7%)
DateAnnualQuarterlyTTM
Jun 2022
-
$42.32M(+19.3%)
$148.44M(+8.0%)
Mar 2022
-
$35.46M(-5.0%)
$137.44M(+4.1%)
Dec 2021
$132.03M(+38.1%)
$37.31M(+11.9%)
$132.03M(+5.0%)
Sep 2021
-
$33.34M(+6.4%)
$125.71M(+8.9%)
Jun 2021
-
$31.32M(+4.2%)
$115.48M(+12.0%)
Mar 2021
-
$30.05M(-3.0%)
$103.08M(+7.9%)
Dec 2020
$95.57M(+18.4%)
$30.99M(+34.1%)
$95.57M(+48.0%)
Sep 2020
-
$23.11M(+22.1%)
$64.58M(+55.7%)
Jun 2020
-
$18.93M(-16.1%)
$41.47M(+12.6%)
Mar 2020
-
$22.54M(+58.0%)
$36.81M(+50.7%)
Dec 2019
$80.73M(+177.7%)
-
-
Jun 2019
-
$14.27M(+40.5%)
$24.42M(+140.5%)
Mar 2019
-
$10.15M
$10.15M
Dec 2018
$29.07M
-
-

FAQ

  • What is Harmony Biosciences Holdings, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. annual SG&A year-on-year change?
  • What is Harmony Biosciences Holdings, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. quarterly SG&A year-on-year change?
  • What is Harmony Biosciences Holdings, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Harmony Biosciences Holdings, Inc.?
  • What is Harmony Biosciences Holdings, Inc. TTM SG&A year-on-year change?

What is Harmony Biosciences Holdings, Inc. annual SG&A?

The current annual SG&A of HRMY is $221.27M

What is the all-time high annual SG&A for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high annual SG&A is $221.27M

What is Harmony Biosciences Holdings, Inc. annual SG&A year-on-year change?

Over the past year, HRMY annual SG&A has changed by +$28.57M (+14.83%)

What is Harmony Biosciences Holdings, Inc. quarterly SG&A?

The current quarterly SG&A of HRMY is $59.36M

What is the all-time high quarterly SG&A for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high quarterly SG&A is $64.00M

What is Harmony Biosciences Holdings, Inc. quarterly SG&A year-on-year change?

Over the past year, HRMY quarterly SG&A has changed by +$3.19M (+5.69%)

What is Harmony Biosciences Holdings, Inc. TTM SG&A?

The current TTM SG&A of HRMY is $275.96M

What is the all-time high TTM SG&A for Harmony Biosciences Holdings, Inc.?

Harmony Biosciences Holdings, Inc. all-time high TTM SG&A is $275.96M

What is Harmony Biosciences Holdings, Inc. TTM SG&A year-on-year change?

Over the past year, HRMY TTM SG&A has changed by +$56.40M (+25.69%)
On this page